期刊文献+

血清VEGF水平在小细胞肺癌诊治中的临床意义 被引量:2

Clinical significance of serum vascular endothelial growth factor in patients with small cell lung cancer
原文传递
导出
摘要 目的探讨血清血管内皮生长因子(serum vascular endothelial growth factor,sVEGF)水平在小细胞肺癌(SCLC)诊治中的临床价值。方法用放射免疫的方法检测69例未经任何治疗的SCLC患者sVEGF水平以及治疗后的sVEGF水平,同时用相同方法检测了50例健康体检者的sVEGF水平作为对照,分析SCLC患者与健康体检者的sVEGF水平差异,并分析SCLC患者sVEGF水平与临床分期及治疗效果之间的关系。结果 SCLC组sVEGF水平[(236.83±72.35)ng/ml]明显高于健康对照组[(114.18±27.57)ng/ml,t=12.853,P<0.001],广泛期患者的sVEGF浓度[(263.09±81.30)ng/ml]高于局限期浓度[(204.63±42.04)ng/ml,t=-3.846,P<0.001],治疗有效组治疗后sVEGF水平[(129.43±29.12)ng/ml]低于治疗前[(236.90±68.76)ng/ml,P<0.05],治疗无效组治疗后sVEGF水平[(236.72±78.60)ng/ml]与治疗前[(258.70±72.93)ng/ml,t=-1.100,P=0.281]无明显变化。结论 sVEGF浓度检测有助于SCLC诊断,监测治疗前后SCLC患者sVEGF浓度变化对评价治疗效果具有积极的意义。 Objective To investigate the clinical value of serum vascular endothelial growth factor(VEGF) levels of patients in th diagnosis and treatment of small cell lung cancer(SCLC).Methods The serum VEGF levels of 69 cases of SCLC and 50 cases of healthy volunteers were detected by radioimmunoassay before and after treatment.To analyze the difference of serum VEGF levels between the patients with SCLC and healthy volunteers,and analyze the serum VEGF levels of patients with SCLC in different clinical stages,and also analyze the relationship between the curative effect and serum VEGF levels.Results Serum VEGF level of patients with SCLC[(236.83±72.35) ng/ml] was obviously higher than control group[(114.18±27.57) ng/ml,t=12.853,P 0.001];Widely period small cell lung cancer[(263.09±81.30) ng/ml] higher than limited stage[(204.63±42.04) ng/ml,t=-3.846,P0.001].The serum VEGF level of effective treatment group[(129.43±29.12) ng/ml] is lower than before[(236.90±68.76) ng/ml,t=10.030,P0.001].The serum VEGF level of ineffective treatment group[(236.72±78.60) ng/ml] chang little than before[(258.70±72.93) ng/ml,t=-1.100,P=0.281].Conclusion The serum VEGF levels measurement is helpful to diagnose small cell lung cancer(SCLC),and monitoring the serum VEGF levels changes of patients with SCLC before and after the treatment to judge the treatment effect of small cell lung cancer has a positive significance.
出处 《中国误诊学杂志》 CAS 2012年第6期1264-1266,共3页 Chinese Journal of Misdiagnostics
关键词 血管内皮生长因子A/代谢 小细胞/诊断/治疗 肺肿瘤/诊断/治疗 Vascular Endothelial Growth Factor A/metabolism Carcinoma Small Cell/diagnosis Lung Neoplasms/diagnosis
  • 相关文献

参考文献5

二级参考文献69

共引文献13

同被引文献28

  • 1吴胤瑛,李恩孝.VEGF在恶性肿瘤中的研究进展[J].现代肿瘤医学,2005,13(5). 被引量:56
  • 2刘军,朱晓华.血管内皮生长因子对小细胞肺癌诊治的应用价值研究[J].中国肺癌杂志,2007,10(5):406-410. 被引量:8
  • 3Faruk Tas, Derya Duranyildiz, Hilal Oguz, et al Vascular Endothe-lial Growth Factor (VEGF) and Interleukin—8 (IL—8) Levels inSmall Cell Lung Cancer[J] Cancer Invest, 2006, 24(5):492-496.
  • 4Fontanini G, Faviana P, Lucchi M, et al A high vascular count andoverexpression of vascular endothelial growth factor are associatedwith unfavorable prognosis in operated small cell lung carcinoma|J| BrJ Cancer, 2002,86(4):558-563.
  • 5Perrot—Applanat M, Di Benedetto M Autocrine functions of VEGFin breast tumor cells: Adhesion, survival, migration and invasion[J]Cell Adh Migr, 2012, 6(6):547-553.
  • 6MaekawaS, Iwasaki A, Shirakusa T, et al Correlation between lymphnode metastasis and the expression of VEGF—C, VEGF—D andVEGFR—3 in T1 lung adenocarcinoma][J] Anticancer Res, 2007, 27(6):3735-3741.
  • 7GisterekI, Matkowski R, KoZlak J, et al Evaluation of prognosticvalue of VEGF— G and VEGF— D in breast cancer 10 years followup analysis [J] Anticancer Res, 2007, 27⑷:2797—2802.
  • 8WaiPY,Kuo PC Osteopontin:regulation in tumor metastasis[J]Cancer Metastasis Review, 2008, 27(1):103-118.
  • 9ZhuYM,Azahri NS, Yu DC Effects of COX—2 inhibition on ex-pression of vascular endothelial growth factor and interleukin—8 inlung cancer cells [J] BMC Cancer, 2008, 8:218.
  • 10Herbst RS, Onn A, Sandler A Angiogenesis and lung cancer:prog-nostic and therapeutic implications[J] J Clin Oncol, 2005,23(14):3243-3256.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部